| Pregnancy |
0 |
0.9 |
| Abortion |
0 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Incomplete Abortion |
0 |
0.49 |
| Social Determinants of Health |
0 |
0.44 |
| Health Care Quality, Access, and Evaluation |
0 |
0.95 |
| Patient Safety |
0 |
0.32 |
| Health Care Reform |
0 |
0.25 |
| COVID-19 |
0 |
0.2 |
| Revenue and Practice Management |
0 |
0.9 |
| Telehealth and Telemedicine |
0 |
0.2 |
| Pandemic |
0 |
0.85 |
| Vaginal Hemorrhage |
0 |
0.18 |
| Adverse Effects |
0 |
0.13 |
| Vagina |
0 |
0.13 |
| Gestational Age |
0 |
0.11 |
| Epilepsy |
0 |
0.1 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.09 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Contraception |
0 |
0.07 |
| Dorsum |
0 |
0.06 |
| Drug and Treatment Safety |
0 |
0.06 |
| Family Planning |
0 |
0.06 |
| Fellowship |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Maryland |
0 |
0.06 |
| Outpatient Clinic |
0 |
0.06 |
| Rural Health |
0 |
0.06 |
| Salary and Compensation |
0 |
0.06 |
| Severe Acute Respiratory Syndrome |
0 |
0.06 |
| Travel Medicine |
0 |
0.06 |